580 related articles for article (PubMed ID: 19368895)
21. Beyond binding: using phage display to select for structure, folding and enzymatic activity in proteins.
Forrer P; Jung S; Plückthun A
Curr Opin Struct Biol; 1999 Aug; 9(4):514-20. PubMed ID: 10449374
[TBL] [Abstract][Full Text] [Related]
22. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.
Fellouse FA; Esaki K; Birtalan S; Raptis D; Cancasci VJ; Koide A; Jhurani P; Vasser M; Wiesmann C; Kossiakoff AA; Koide S; Sidhu SS
J Mol Biol; 2007 Nov; 373(4):924-40. PubMed ID: 17825836
[TBL] [Abstract][Full Text] [Related]
23. Aromatic residues engineered into the beta-turn nucleation site of ubiquitin lead to a complex folding landscape, non-native side-chain interactions, and kinetic traps.
Rea AM; Simpson ER; Meldrum JK; Williams HE; Searle MS
Biochemistry; 2008 Dec; 47(48):12910-22. PubMed ID: 18991391
[TBL] [Abstract][Full Text] [Related]
24. High solubility of random-sequence proteins consisting of five kinds of primitive amino acids.
Doi N; Kakukawa K; Oishi Y; Yanagawa H
Protein Eng Des Sel; 2005 Jun; 18(6):279-84. PubMed ID: 15928003
[TBL] [Abstract][Full Text] [Related]
25. Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
Sommerhoff CP; Avrutina O; Schmoldt HU; Gabrijelcic-Geiger D; Diederichsen U; Kolmar H
J Mol Biol; 2010 Jan; 395(1):167-75. PubMed ID: 19852971
[TBL] [Abstract][Full Text] [Related]
26. Natural-like function in artificial WW domains.
Russ WP; Lowery DM; Mishra P; Yaffe MB; Ranganathan R
Nature; 2005 Sep; 437(7058):579-83. PubMed ID: 16177795
[TBL] [Abstract][Full Text] [Related]
27. Alternative non-antibody scaffolds for molecular recognition.
Skerra A
Curr Opin Biotechnol; 2007 Aug; 18(4):295-304. PubMed ID: 17643280
[TBL] [Abstract][Full Text] [Related]
28. Better library design: data-driven protein engineering.
Chaparro-Riggers JF; Polizzi KM; Bommarius AS
Biotechnol J; 2007 Feb; 2(2):180-91. PubMed ID: 17183506
[TBL] [Abstract][Full Text] [Related]
29. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
Nygren PA
FEBS J; 2008 Jun; 275(11):2668-76. PubMed ID: 18435759
[TBL] [Abstract][Full Text] [Related]
30. Sequence and structure space of RNA-binding peptides.
Das C; Frankel AD
Biopolymers; 2003 Sep; 70(1):80-5. PubMed ID: 12925994
[TBL] [Abstract][Full Text] [Related]
31. The cyclotides and related macrocyclic peptides as scaffolds in drug design.
Craik DJ; Cemazar M; Daly NL
Curr Opin Drug Discov Devel; 2006 Mar; 9(2):251-60. PubMed ID: 16566295
[TBL] [Abstract][Full Text] [Related]
32. Construction of proteins with molecular recognition capabilities using α3β3 de novo protein scaffolds.
Okura H; Mihara H; Takahashi T
Protein Eng Des Sel; 2013 Oct; 26(10):705-11. PubMed ID: 24046439
[TBL] [Abstract][Full Text] [Related]
33. Engineering knottins as novel binding agents.
Moore SJ; Cochran JR
Methods Enzymol; 2012; 503():223-51. PubMed ID: 22230571
[TBL] [Abstract][Full Text] [Related]
34. Structural determinants of the unusual helix stability of a de novo engineered vascular endothelial growth factor (VEGF) mimicking peptide.
Diana D; Ziaco B; Colombo G; Scarabelli G; Romanelli A; Pedone C; Fattorusso R; D'Andrea LD
Chemistry; 2008; 14(14):4164-6. PubMed ID: 18384035
[No Abstract] [Full Text] [Related]
35. Conformational control of inorganic adhesion in a designer protein engineered for cuprous oxide binding.
Choe WS; Sastry MS; Thai CK; Dai H; Schwartz DT; Baneyx F
Langmuir; 2007 Nov; 23(23):11347-50. PubMed ID: 17918983
[TBL] [Abstract][Full Text] [Related]
36. Engineered staphylococcal protein A's IgG-binding domain with cathepsin L inhibitory activity.
Bratkovic T; Berlec A; Popovic T; Lunder M; Kreft S; Urleb U; Strukelj B
Biochem Biophys Res Commun; 2006 Oct; 349(1):449-53. PubMed ID: 16935262
[TBL] [Abstract][Full Text] [Related]
37. Design of a novel heme protein with a non-heme globin scaffold.
Isogai Y; Ishida M
Biochemistry; 2009 Sep; 48(34):8136-42. PubMed ID: 19601582
[TBL] [Abstract][Full Text] [Related]
38. De novo design of proteins. Template-assembled synthetic proteins (TASP).
Tuchscherer G; Steiner V; Altmann KH; Mutter M
Methods Mol Biol; 1994; 36():261-85. PubMed ID: 7697113
[No Abstract] [Full Text] [Related]
39. Assessing computational amino acid beta-turn propensities with a phage-displayed combinatorial library and directed evolution.
Hsu HJ; Chang HJ; Peng HP; Huang SS; Lin MY; Yang AS
Structure; 2006 Oct; 14(10):1499-510. PubMed ID: 17027499
[TBL] [Abstract][Full Text] [Related]
40. A carbohydrate binding module as a diversity-carrying scaffold.
Cicortas Gunnarsson L; Nordberg Karlsson E; Albrekt AS; Andersson M; Holst O; Ohlin M
Protein Eng Des Sel; 2004 Mar; 17(3):213-21. PubMed ID: 15082834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
